RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q4 2010
Dec 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
ORG Informatics Limited (517195) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
Deals and alliances in musculoskeletal diseases
Jun 2006 - 378 pages - $2,495
CREDIT ORG OF S&M ENTPRS (8489) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q2 2011
Apr 2011 - 91 pages - $500
ORG Informatics Limited (517195) - Financial and Strategic SWOT Analysis Review
Mar 2011 - 25 pages - $125
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2011
Aug 2011 - 94 pages - $500
Organon: PharmaVitae Profile
Oct 2007 - 159 pages - $5,700
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
News sources del
Therapeutic target
Musculoskeletal del
Scleroderma del
Year
2001 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us